Angel News
Angel News
Angel News

Back to Homepage

21st November 2018

The Riverside Company’s latest exit a natural success

The Riverside Company has signed a definitive agreement to sell its investment in Euromed Botanicals S.A. to Dermapharm Holding SE. Barcelona-based Euromed provides standardized herbal extracts and natural active substances for the pharmaceutical, dietary supplement and cosmetic industries. The transaction is expected to close in the next few months upon receipt of antitrust approval. 

19th November 2018

Inovus Medical set to expand following £500k Mercia investment

Inovus Medical, a leading designer and manufacturer of medical and surgical simulators, has announced the successful completion of a £500,000 investment from NPIF - Mercia Equity Finance, which is managed by Mercia Fund Managers and part of the Northern Powerhouse Investment Fund.

The investment is part of a £700,000 investment round alongside an angel investor and will help to create four new jobs, accelerating the growth of Inovus Medical’s commercial operations in the domestic and international markets.

The company also plans to utilise the funding to add a suite of new 3D printing technologies to its manufacturing processes and introduce new software additions to its existing product offering.

15th November 2018

Albion Capital invests £5m in women’s health clinic

Albion Capital, the leading independent investment manager, has invested £5 million in The Evewell, a fully-integrated centre of medical excellence dedicated to caring for and protecting all aspects of fertility and gynaecological health.  The centre, which opened on Harley Street in London this month, focuses on both gynaecology and reproductive health to ensure that fertility patients receive the most appropriate treatment and advice to maximise their prospects of conceiving. It offers a fully integrated suite of women’s health services that differentiates it from other clinics. The clinic is equipped with the latest technologies for screening and treatment, and is set in a discreet and luxurious environment that provides a best-in-class service.

12th November 2018

FreeOx Biotech closes €500,000 funding round

FreeOx Biotech, a spin-out of Hospital Clinic Barcelona-IDIBAPS created in 2017 that is developing a new class of neuroprotective drugs, has closed its first round of funding with €500,000 from private investors Montserrat Esteve and Francisco Javier Alsina.

8th November 2018

Medherant positive Phase I results for drug delivery patch

Mercia Technologies investment Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has successfully completed two Phase I studies with its novel Ibuprofen TEPI® Patch.

The TEPI Patch was shown to be well tolerated by all subjects in a study of skin irritation and sensitisation. This marks the first clinical safety evaluation of Medherant’s novel adhesive, facilitating the development of the next generation of drug-in-adhesive patches.

29th October 2018

PBD Biotech secures grant of key patent for its new bacterial diagnostic technology

Suffolk-based biotechnology company, PBD Biotech Ltd, has announced that its key technology patent has been granted by the European Patent Office, covering its Actiphage technology that allows the sensitive and specific detection of live bacteria within six hours.

24th October 2018

Maven Capital Partners completes investment in Acton Banks

Maven Capital Partners has led the management buyout of Acton Banks Limited, a market leading UK healthcare staffing business. The transaction is Maven’s third investment from its buyout fund, having earlier this year led an investment in Manchester-based hardware designer and supplier UAP Limited and Glasgow-based John McGavigan Limited, a leader in decorative technology used in the automotive sector.

24th October 2018

Patient-data platform Raremark raises £3m

Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.

22nd October 2018

Master Investor 'Investing in the Age of Longevity' takes place on 1 November

Master Investor's "Investing in the age of Longevity" takes place on 1st November 2018 at the Wellcome Collection in London

16th October 2018

Stride and Albion back Forward Health's $3.9m fundraising

Forward Health, the app working to reinvent healthcare communication, has raised a $3.9m seed funding-round led by Stride.VC, with additional backing from Albion Capital. The funds are joined by an impressive roster of angel backers, including healthtech founders Jay Desai from US company Patient Ping and Melissa Morris from UK-based Lantum.

Forward was founded in 2016 by UK doctors Barney Gilbert and Lydia Yarlott, alongside serial entrepreneur Philip Mundy. Their mission is to connect healthcare systems around the world, making communication secure, transparent and flexible for healthcare professionals and patients.

15th October 2018

Par Equity invests £1.3m in Censo

Edinburgh-based venture capital firm Par Equity has invested £1.3m in a rapidly growing stem-cell research company that is helping pharmaceutical giants to develop new treatments for diseases including Parkinson’s and Alzheimer’s.

10th October 2018

EQT leads €4.5 million fundraising for Siilo

Siilo, the secure instant messaging app for healthcare professionals, has raised a €4.5 million funding round. Lead investor in the round is the EQT Ventures fund with participation from existing investors. The funding will be used to scale-up Siilo’s user base across Europe, with a particular focus on the UK and Germany.

Medical professionals are faced with an increasingly fragmented healthcare system and outdated methods of communication, such as fax, pagers and landlines. This often results in key patient data being siloed and valuable time being wasted trying to get access to the right information. To ensure the right teams have access to vital patient data at the right time, healthcare professionals have taken matters into their own hands. According to British Medical Journal research, 98.9% of UK hospital clinicians now have smartphones, with about a third using consumer messaging apps in the clinical workplace.

PREVIOUSItems 12 of 110NEXT

Back to Homepage